A potential platform for developing 3D tubular scaffolds for paediatric organ development

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 3, 2015, Pages

  de Mel, Achala ^a   Yap, Trixie ^a   Cittadella, Giorgio ^a   Hale, Luke Richard ^a   Maghsoudlou, Panagiotis ^b   de Coppi, Paolo ^b   Birchall, Martin A ^c   Seifalian, Alexander M ^a,d  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CYTOLOGY; INTEGRATION; MUSCLE; PEDIATRICS; PHYSIOLOGICAL MODELS; STEM CELLS; TENSILE STRENGTH; TOPOGRAPHY; UREA;

ADIPOSE DERIVED STEM CELLS; BIOPHYSICAL PARAMETERS; CHORIOALLANTOIC MEMBRANE ASSAYS; HUMAN ADIPOSE DERIVED STEM CELLS; PHYSICOMECHANICAL PROPERTIES; PHYSIOLOGICAL SYSTEMS; POLY (EPSILONCAPROLACTONE); POLYHEDRAL OLIGOMERIC SILSESQUIOXANES;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 4; NANOCOMPOSITE; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE POLY(EPSILON CAPROLACTONE)UREA URETHANE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ARTICLE; CELL INTERACTION; CHORIOALLANTOIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; NANOFABRICATION; ORGANOGENESIS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; TENSILE STRENGTH; THICKNESS; TISSUE ENGINEERING; TISSUE SCAFFOLD; TOPOGRAPHY; YOUNG MODULUS; CELL CULTURE; CHILD;

CELLS, CULTURED; CHILD; HUMANS; TISSUE SCAFFOLDS;

EID: 84924205644     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5477-4     Document Type: Article

References (39)

1. Basu J, Ludlow JW. Platform technologies for tubular organ regeneration. Trends Biotechnol. 2010;28(10):526–33.
2. Vacanti JP. Tissue engineering and the road to whole organs. Br J Surg. 2012;99(4):451–3.
3. Del GC, Baiguera S, Ajalloueian F, Bianco A, Macchiarini P. Are synthetic scaffolds suitable for the development of clinical tissue-engineered tubular organs? J Biomed Mater Res A. 2013;102(7):2427–47.
4. Birchall MA. Cell-and tissue-engineered organ replacements. Br J Surg. 2009;96(6):565–6.
5. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs. 2002;26(4):307–20.
6. Yannas IV. Emerging rules for inducing organ regeneration. Biomaterials. 2013;34(2):321–30.
7. Post MJ, Rahimi N, Caolo V. Update on vascularization in tissue engineering. Regen Med. 2013;8(6):759–70.
8. Jungebluth P, Alici E, Baiguera S, Le BK, Blomberg P, Bozoky B, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet. 2011;378(9808):1997–2004.
9. Ahmed M, Hamilton G, Seifalian AM. The performance of a small-calibre graft for vascular reconstructions in a senescent sheep model. Biomaterials. 2014;35(33):9033–40.
10. Chaloupka K, Motwani M, Seifalian AM. Development of a new lacrimal drainage conduit using POSS nanocomposite. Biotechnol Appl Biochem. 2011;58(5):363–70.
11. Cittadella G, de Mel A, Dee R, De CP, Seifalian AM. Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts. Artif Organs. 2013;37(5):423–34.
12. Yildirimer L, Seifalian AM. Sterilization-induced changes in surface topography of biodegradable POSS-nanocomposite and the cellular response of human dermal fibroblasts. Tissue Eng Part C Methods. 2014. doi:10.1089/ten.TEC.2014.0270.
13. de Mel A, Seifalian AM, Birchall MA. Orchestrating cell/material interactions for tissue engineering of surgical implants. Macromol Biosci. 2012;12(8):1010–21.
14. Hollister SJ. Porous scaffold design for tissue engineering. Nat Mater. 2005;4(7):518–24.
15. Freed LE, Engelmayr GC Jr, Borenstein JT, Moutos FT, Guilak F. Advanced material strategies for tissue engineering scaffolds. Adv Mater. 2009;21(32–33):3410–8.
16. Seol YJ, Kang HW, Lee SJ, Atala A, Yoo JJ. Bioprinting technology and its applications. Eur J Cardiothorac Surg. 2014;46(3):342–8.
17. Mun CH, Jung Y, Kim SH, Kim HC, Kim SH. Effects of pulsatile bioreactor culture on vascular smooth muscle cells seeded on electrospun poly (lactide-co-epsilon-caprolactone) scaffold. Artif Organs. 2013;37(12):E168–78.
18. Sarkar S, Burriesci G, Wojcik A, Aresti N, Hamilton G, Seifalian AM. Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer. J Biomech. 2009;42(6):722–30.
19. Ahmed M, Ghanbari H, Cousins BG, Hamilton G, Seifalian AM. Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater. 2011;7(11):3857–67.
20. Seifalian AM, Salacinski HJ, Punshon G, Krijgsman B, Hamilton G. A new technique for measuring the cell growth and metabolism of endothelial cells seeded on vascular prostheses. J Biomed Mater Res. 2001;55(4):637–44.
21. de Mel A, Ramesh B, Scurr DJ, Alexander MR, Hamilton G, Birchall M, et al. Fumed silica nanoparticle mediated biomimicry for optimal cell-material interactions for artificial organ development. Macromol Biosci. 2014;14(3):307–13.
22. Totonelli G, Maghsoudlou P, Garriboli M, Riegler J, Orlando G, Burns AJ, et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials. 2012;33(12):3401–10.
23. Yildirimer L, Seifalian AM. Three-dimensional biomaterial degradation—material choice, design and extrinsic factor considerations. Biotechnol Adv. 2014;32(5):984–99.
24. Sarkar S, Hillery C, Seifalian A, Hamilton G. Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used. J Vasc Surg. 2006;44(4):846–52.
25. Partington L, Mordan NJ, Mason C, Knowles JC, Kim HW, Lowdell MW, et al. Biochemical changes caused by decellularization may compromise mechanical integrity of tracheal scaffolds. Acta Biomater. 2013;9(2):5251–61.
26. Loh QL, Choong C. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev. 2013;19(6):485–502.
27. Seo CH, Jeong H, Furukawa KS, Suzuki Y, Ushida T. The switching of focal adhesion maturation sites and actin filament activation for MSCs by topography of well-defined micropatterned surfaces. Biomaterials. 2013;34(7):1764–71.
28. Nakamoto T, Wang X, Kawazoe N, Chen G. Influence of micropattern width on differentiation of human mesenchymal stem cells to vascular smooth muscle cells. Colloids Surf B Biointerfaces. 2014;122C:316–23.
29. Zhao J, Liu L, Wei J, Ma D, Geng W, Yan X, et al. A novel strategy to engineer small-diameter vascular grafts from marrow-derived mesenchymal stem cells. Artif Organs. 2012;36(1):93–101.
30. Khani MM, Tafazzoli-Shadpour M, Rostami M, Peirovi H, Janmaleki M. Evaluation of mechanical properties of human mesenchymal stem cells during differentiation to smooth muscle cells. Ann Biomed Eng. 2014;42(7):1373–80.
31. Orbay H, Tobita M, Mizuno H. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int. 2012;2012:461718.
32. Wilson A, Butler PE, Seifalian AM. Adipose-derived stem cells for clinical applications: a review. Cell Prolif. 2011;44(1):86–98.
33. Lanfranchi A, Porta F, Chirico G. Stem cells and the frontiers of neonatology. Early Hum Dev. 2009;85(10 Suppl):S15–8.
34. Lin CH, Lilly B. Endothelial cells direct mesenchymal stem cells toward a smooth muscle cell fate. Stem Cells Dev. 2014;23(21):2581–90.
35. Khalil AS, Xie AW, Murphy WL. Context clues: the importance of stem cell-material interactions. ACS Chem Biol. 2013;9(1):45–56.
36. Guasti L, Vagaska B, Bulstrode NW, Seifalian AM, Ferretti P. Chondrogenic differentiation of adipose tissue-derived stem cells within nanocaged POSS-PCU scaffolds: a new tool for nanomedicine. Nanomedicine. 2013;10(2):279–89.
37. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008;22(6):1635–48.
38. Huang JI, Zuk PA, Jones NF, Zhu M, Lorenz HP, Hedrick MH, et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plast Reconstr Surg. 2004;113(2):585–94.
39. Wang C, Yin S, Cen L, Liu Q, Liu W, Cao Y, et al. Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng Part A. 2010;16(4):1201–13.